Clinical Trial Update: A Phase 4 Clinical Study to Investigate the Efficacy and Safety of Naloxone HCI IV in Patients With Stroke [Phase 4]

View source ↗

Summary

Phase 4 clinical study investigating the efficacy and safety of Naloxone HCI IV in patients with acute stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke Acute

Drugs mentioned

• Naloxone HCI IV (naloxone hydrochloride intravenous)

Snippet

Sponsor: Samjin Pharmaceutical Co., Ltd. | Conditions: Stroke, Acute | Phase 4 | Status: COMPLETED